Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cassava Sciences Inc 6801 N. CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 USA

www.cassavasciences.com Employees: 30 P: 512-501-2444

Sector:

Medical

Description:

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 103,862
Enterprise Value, $K -24,708
Shares Outstanding, K 48,308
Float, K 47,149
% Float 97.60%
Short Interest, K 6,853
Short Float 14.18%
Days to Cover 9.01
Short Volume Ratio 0.30
% of Insider Shareholders 2.40%
% of Institutional Shareholders 38.05%
Annual Net Income, $ -24,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,810 K
EBIT, $ -111,330 K
EBITDA, $ -110,200 K
3-Year Return -93.83%
5-Year Return -83.29%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -1,300.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 11/12/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -1.45
EPS Growth vs. Prev Qtr -22.22%
EPS Growth vs. Prev Year 62.07%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.750 on 12/13/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 05/10/17

SAVA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.39%
Return-on-Assets % -49.81%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.21
Book Value/Share 1.69
Interest Coverage -0.66
60-Month Beta -1.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar